Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers

  1. Bajo, A.M.
  2. Schally, A.V.
  3. Halmos, G.
  4. Nagy, A.
Aldizkaria:
Clinical Cancer Research

ISSN: 1078-0432

Argitalpen urtea: 2003

Alea: 9

Zenbakia: 10 I

Orrialdeak: 3742-3748

Mota: Artikulua

GOOGLE SCHOLAR
Datuen iturria: Scopus